UY30047A1 - STROGEN MODULATORS - Google Patents

STROGEN MODULATORS

Info

Publication number
UY30047A1
UY30047A1 UY30047A UY30047A UY30047A1 UY 30047 A1 UY30047 A1 UY 30047A1 UY 30047 A UY30047 A UY 30047A UY 30047 A UY30047 A UY 30047A UY 30047 A1 UY30047 A1 UY 30047A1
Authority
UY
Uruguay
Prior art keywords
modulators
strogen
isoxazoles
present application
new class
Prior art date
Application number
UY30047A
Other languages
Spanish (es)
Inventor
Veerabahu Shanmugasundaram
Raj Kumar Raheja
Lorna Helen Mitchell
Sandra Marie Jennings
Stephen Douglas Barrett
Stephen Alan Fakhoury
Larry Don Bratton
Simon Bailey
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of UY30047A1 publication Critical patent/UY30047A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/08—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing alicyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/08—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing alicyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Abstract

La presente solicitud se refiere a una nueva clase de isoxazoles y a su uso como moduladores de estrógenos.The present application refers to a new class of isoxazoles and their use as estrogen modulators.

UY30047A 2005-12-22 2006-12-20 STROGEN MODULATORS UY30047A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75278005P 2005-12-22 2005-12-22
US80523306P 2006-06-20 2006-06-20

Publications (1)

Publication Number Publication Date
UY30047A1 true UY30047A1 (en) 2007-07-31

Family

ID=38066616

Family Applications (1)

Application Number Title Priority Date Filing Date
UY30047A UY30047A1 (en) 2005-12-22 2006-12-20 STROGEN MODULATORS

Country Status (17)

Country Link
US (2) US7470715B2 (en)
EP (1) EP1966170A2 (en)
JP (1) JP2009520808A (en)
KR (1) KR20080073346A (en)
AP (1) AP2008004481A0 (en)
AR (1) AR058611A1 (en)
AU (1) AU2006327877A1 (en)
BR (1) BRPI0620215A2 (en)
CA (1) CA2628596A1 (en)
EA (1) EA200801407A1 (en)
EC (1) ECSP088533A (en)
NL (1) NL2000351C2 (en)
NO (1) NO20082992L (en)
PE (1) PE20070815A1 (en)
RS (1) RS20080267A (en)
UY (1) UY30047A1 (en)
WO (1) WO2007072164A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20130097748A (en) * 2010-08-10 2013-09-03 아비에 인코포레이티드 Novel trpv3 modulators
CN111938907B (en) * 2020-08-12 2022-07-01 中国人民解放军陆军军医大学第一附属医院 External application face mask after nasal operation

Family Cites Families (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US207927A (en) * 1878-09-10 Improvement in horse hay-rakes
US9799A (en) * 1853-06-21 Simon ikgeksoll
US525666A (en) * 1894-09-04 Axel sarnmark
US256210A (en) * 1882-04-11 Bodolphe t
US171412A (en) * 1875-12-21 Improvement in buck-boards
GB1012182A (en) 1963-04-23 1965-12-08 Ass Portland Cement Improvement in the manufacture of hydraulic cement
JPS63108339A (en) 1986-10-27 1988-05-13 Fuji Photo Film Co Ltd Method for processing silver halide color photosensitive material
GB2201672A (en) 1986-12-18 1988-09-07 Shell Int Research Diphenyl ether compounds
US4952700A (en) 1988-04-25 1990-08-28 W.R. Grace & Co.-Conn. Preparation of isoxazolines and isoxazoles
US4933464A (en) * 1988-04-25 1990-06-12 W. R. Grace & Co.-Conn. Process for forming 3-phenylisoxazolines and 3-phenylisoxazoles
JPH089599B2 (en) 1988-08-02 1996-01-31 三井東圧化学株式会社 Process for producing pyrazole carboxylic acids
JPH089600B2 (en) 1988-08-02 1996-01-31 三井東圧化学株式会社 Process for producing pyrazole carboxylic acids
IT1228288B (en) 1989-01-09 1991-06-07 Zambon Spa COMPOUNDS WITH ANTI-SEROTONIN ACTIVITY
DE4016049A1 (en) * 1990-05-18 1991-11-21 Basf Ag 3-ISOXAZOLYLBYL CYLESTER, THEIR PRODUCTION AND USE
US5256632A (en) * 1990-05-30 1993-10-26 Bayer Aktiengesellschaft Herbicidal sulphonylated carboxamides
DK178590D0 (en) 1990-07-26 1990-07-26 Novo Nordisk As 1,4-DISUBSTITUTED PIPERAZINES
US5260322A (en) 1990-10-08 1993-11-09 Merck & Co., Inc. Angiotension II antagonists in the treatment of hyperuricemia
JP3010387B2 (en) 1991-05-13 2000-02-21 コニカ株式会社 Pyrazole derivatives
JP3454531B2 (en) * 1991-11-07 2003-10-06 三共株式会社 Nitroxyalkylamide derivatives
DE4137940A1 (en) 1991-11-18 1993-05-19 Basf Ag 3-ISOXAZOLYLPHENYL COMPOUNDS, THEIR PRODUCTION AND THEIR USE
WO1994017059A1 (en) 1993-01-29 1994-08-04 Nippon Soda Co., Ltd. Heterocyclic derivative
IT1263751B (en) 1993-02-05 1996-08-27 Mini Ricerca Scient Tecnolog ARILACETIC ESTERS DERIVED FROM FUNGICIDE ACTIVITIES
JPH06236057A (en) 1993-02-10 1994-08-23 Fuji Xerox Co Ltd Electrophotographic sensitive body
JPH07304748A (en) 1993-06-29 1995-11-21 Nissan Chem Ind Ltd Aldoxime derivative and agricultural and horticultural germicide
WO1995011896A1 (en) 1993-10-26 1995-05-04 Nissan Chemical Industries, Ltd. Substituted pyrazole derivative and agrohorticultural fungicide
JP3791015B2 (en) 1994-03-31 2006-06-28 日産化学工業株式会社 Method for producing sulfonamide derivative
JP3329061B2 (en) 1994-04-19 2002-09-30 三菱化学株式会社 Electrophotographic photoreceptor
JPH0873436A (en) 1994-07-06 1996-03-19 Nissan Chem Ind Ltd Semicarbazone derivative
US5486534A (en) 1994-07-21 1996-01-23 G. D. Searle & Co. 3,4-substituted pyrazoles for the treatment of inflammation
FR2725988B1 (en) 1994-10-24 1997-01-24 Roussel Uclaf NEW DERIVATIVES OF PYRAZOLONES AND ACID PYRAZOLES, THEIR PROCESS OF PREPARATION, THE NEW INTERMEDIARIES OBTAINED, THEIR APPLICATION AS MEDICINAL PRODUCTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
CN1117080A (en) 1995-01-11 1996-02-21 刘波 Bacillus thuringiensis culture medium
ES2183935T3 (en) * 1995-02-13 2003-04-01 Searle & Co SUBSTITUTED ISOXAZOLS FOR THE TREATMENT OF INFLAMMATION.
WO1996033994A1 (en) 1995-04-28 1996-10-31 Nippon Soda Co., Ltd. Amino-substituted derivatives, process for the preparation thereof, and herbicide
ATE301457T1 (en) * 1995-06-12 2005-08-15 Searle & Co AGENT CONTAINING A CYCLOOXYGENASE-2 INHIBITOR AND A 5-LIPOXYGENASE INHIBITOR
NZ322674A (en) 1995-10-17 1999-08-30 Searle & Co Method of detecting cyclooxygenase-2
EP0880363B1 (en) 1996-02-13 2002-09-11 G.D. SEARLE & CO. Combinations, having immunosuppressive effects, containing a cyclooxygenase-2 inhibitor and a leukotriene a 4 hydrolase inhibitor
DE69719496T2 (en) 1996-04-12 2004-04-08 G.D. Searle & Co., Chicago N - [[4- (5-METHYL-3-PHENYLISOXAZOL-4-YL] PHENYL] SULPHONYL PROPYLAMIDE and its SODIUM SALT AS A PRO PHARMACONE OF COX-2 INHIBITORS
JP3399756B2 (en) * 1996-10-22 2003-04-21 三菱製紙株式会社 Lithographic printing plate processing method
DE59807486D1 (en) * 1997-09-05 2003-04-17 Basf Ag METHOD FOR PRODUCING (HETERO) AROMATIC HYDROXYLAMINE
CA2372912C (en) 1997-10-14 2008-12-02 G.D. Searle & Co. Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia
US5972986A (en) * 1997-10-14 1999-10-26 G.D. Searle & Co. Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia
JPH11124306A (en) 1997-10-22 1999-05-11 Nissan Chem Ind Ltd Insecticidal, acaricidal and fungicidal composition
ATE315033T1 (en) * 1998-08-07 2006-02-15 Chiron Corp SUBTITUTED ISOXAZOLE DERIVATIVES AS ESTROGEN RECEPTOR MODULATORS
AU1199600A (en) 1998-10-02 2000-04-26 Board Of Trustees Of The University Of Illinois, The Estrogen receptor ligands
WO2000055137A1 (en) * 1999-03-17 2000-09-21 Signal Pharmaceuticals, Inc. Compounds and methods for modulation of estrogen receptors
AU3253800A (en) 1999-05-14 2000-11-16 Pfizer Products Inc. Combination therapy for the treatment of migraine
US6413965B1 (en) 1999-06-30 2002-07-02 Pfizer Inc. Compositions and treatment for diabetic complications
CO5190678A1 (en) 1999-06-30 2002-08-29 Pfizer Prod Inc COMBINED THERAPY FOR THE TREATMENT OF MIGRANA
JP4645871B2 (en) 1999-09-24 2011-03-09 日本農薬株式会社 Isoxazoline derivatives, herbicides and methods of use thereof
JP2003515608A (en) 1999-12-02 2003-05-07 ノバルティス アクチエンゲゼルシャフト Aminoheterocyclylamides as insecticides and anthelmintics
EP1296971A2 (en) 2000-04-25 2003-04-02 Pharmacia Corporation 2-fluorobenzenesulfonyl compounds for the treatment of inflammation
JP2001302662A (en) 2000-04-27 2001-10-31 Nissan Chem Ind Ltd Acrylonitrile compound
AU2002226965B2 (en) 2000-11-27 2006-05-18 Merck Sharp & Dohme Corp. Estrogen receptor modulators
US6693295B2 (en) * 2000-12-25 2004-02-17 Fuji Photo Film Co., Ltd. Indole derivative, material for light-emitting device and light-emitting device using the same
WO2002079163A1 (en) 2001-03-30 2002-10-10 Smithkline Beecham Corporation Aminopyridine derivatives as estrogen receptor modulators
US6673818B2 (en) 2001-04-20 2004-01-06 Pharmacia Corporation Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation
EP1270535A3 (en) * 2001-06-20 2004-02-18 Clariant GmbH Method to synthesise substituted aromatic compounds
US6884814B2 (en) 2001-12-13 2005-04-26 Wyeth Phenyl benzisoxazoles as estrogenic agents
US6960607B2 (en) 2001-12-13 2005-11-01 Wyeth Naphthyl benzoxazoles and benzisoxazoles as estrogenic agents
GB0130339D0 (en) 2001-12-19 2002-02-06 Lilly Co Eli Isochroman compounds
AU2002356301A1 (en) 2001-12-21 2003-07-15 Cancer Research Technology Ltd. 3,4-diarylpyrazoles and their use in the therapy of cancer
WO2003057215A1 (en) 2001-12-28 2003-07-17 Takeda Chemical Industries, Ltd. Neurotrophic factor production/secretion accelerator
US6803379B2 (en) * 2002-06-04 2004-10-12 Jose A. Fernandez-Pol Pharmacological agents and methods of treatment that inactivate pathogenic prokaryotic and eukaryotic cells and viruses by attacking highly conserved domains in structural metalloprotein and metalloenzyme targets
AU2003251768A1 (en) 2002-07-03 2004-01-23 Ortho-Mcneil Pharmaceutical, Inc. Estrieno[3,2-b]/[3,4-c]pyrrole derivatives useful as modulators of the estrogen receptors
WO2004026887A2 (en) 2002-09-19 2004-04-01 Merck & Co., Inc. Estrogen receptor modulators
CA2512000C (en) 2002-12-26 2011-08-09 Eisai Co., Ltd. Selective estrogen receptor modulator
WO2004073610A2 (en) 2003-02-13 2004-09-02 Merck & Co., Inc. Estrogen receptor modulators
WO2004073612A2 (en) 2003-02-13 2004-09-02 Merck & Co. Inc. Estrogen receptor modulators
CN1798721A (en) 2003-05-31 2006-07-05 詹森药业有限公司 Cyclohexyl derivatives as selective estrogen receptor modulators
ES2307068T3 (en) 2003-10-08 2008-11-16 Smithkline Beecham Corporation TRIFENILETILENE COMPOUNDS AS SELECTIVE MODULARS OF STROGEN RECEPTORS.
JP2007536238A (en) 2004-05-04 2007-12-13 アカディア ファーマシューティカルズ，インコーポレーテッド Compounds with activity at the estrogen receptor

Also Published As

Publication number Publication date
PE20070815A1 (en) 2007-08-27
KR20080073346A (en) 2008-08-08
WO2007072164A2 (en) 2007-06-28
JP2009520808A (en) 2009-05-28
ECSP088533A (en) 2008-07-30
US7470715B2 (en) 2008-12-30
NL2000351A1 (en) 2007-06-25
AP2008004481A0 (en) 2008-06-30
NL2000351C2 (en) 2007-09-11
EA200801407A1 (en) 2008-10-30
CA2628596A1 (en) 2007-06-28
AR058611A1 (en) 2008-02-13
AU2006327877A1 (en) 2007-06-28
RS20080267A (en) 2009-05-06
BRPI0620215A2 (en) 2011-11-01
NO20082992L (en) 2008-09-22
WO2007072164A3 (en) 2007-10-04
US20090131397A1 (en) 2009-05-21
US20070149564A1 (en) 2007-06-28
EP1966170A2 (en) 2008-09-10

Similar Documents

Publication Publication Date Title
AR067815A1 (en) ELECTRODEPOSITABLE COATING COMPOSITION CONTAINING A CYCLIC GUANIDINE
CR11523A (en) WISE FIXING AND EPITHOPE AGENTS
HN2006016313A (en) DERIVATIVES OF REPLACED AMIDA AND METHODS OF USE
DOP2006000290A (en) ESTROGEN MODULATORS
NI201200020A (en) DERIVATIVES OF N1 - SULFONIL - 5 - FLUOROPYRIMIDINONE
AR072901A1 (en) USE OF 5- FLUORCITOSINE AS A FUNGICIDE
CR20140398A (en) ANTI-CD22 ANTIBODIES AND IMMUNOCADES
CR11267A (en) SOLID PREPARATION CONTAINING ALOGLIPTINE AND METFORMIN CHLORHYDRATE
CR20110453A (en) COMBINATION OF A NUCLÉOSIDO POLYMERASE INHIBITOR WITH A MACROCYCLY PROTEASE INHIBITOR AND ITS USE IN THE TREATMENT OF HEPATITIS C, HEPATIC FIBROSIS AND ALTERED HEPATIC FUNCTION
CR10372A (en) ANTI-TAT226 ANTIBODIES AND IMMUNOCATE PLAYERS
ECSP066761A (en) ANDROGEN RECEIVER MODULATORS
UY33754A (en) MONOBACTAMAS
CL2008002041A1 (en) Piperidine derived compounds; pharmaceutical composition comprising said compounds; and its use to treat anxiety.
CO6341476A2 (en) DERIVATIVES OF PIRIDINO-PIRIDINONAS, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS
CL2009001804A1 (en) Use of a vinylamine-vinylformamide copolymer and a carrier to prepare a composition for strengthening keratinous fibers.
CR20110034A (en) CRKL SIGNALING PEPTIDES
UY31152A1 (en) DERIVATIVES OF 7-ALQUINIL-1,8-NAFTIRIDONAS, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS
BRPI0815373A2 (en) CYCLE-HEXENE DERIVATIVES AND THE USE OF THEM AS FRAGRANCES
GT200500263A (en) ENZIMA LACASA NOVEDOSA AND ITS USE
ES2422173T3 (en) Compositions containing aecuorin and procedures for their use
CL2009000665A1 (en) Pyrrolidinyl derived compounds; pharmaceutical composition comprising said compounds; and its use in the treatment of anxiety, depression or both.
UY29594A1 (en) DERIVATIVES OF BENZOTIAZOL-2-ONA AS INHIBITORS OF LIPASES AND PHOSPHOLIPASES
UY31139A1 (en) CRYSTALLINE FORMS OF 3- (2R-TETRAHIDROFURIL-METHYL) -2-THIOXANTINE
BRPI0907043A2 (en) Composition, use of compost, and compost
ECSP088533A (en) ESTROGEN MODULATORS

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20160928